Accolade Sr
Payments companies reported to CMS as associated with Accolade Sr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Accolade Sr, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Accolade Sr
These are the largest totals companies reported as associated with Accolade Sr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Amaro | New York, NY | $71,052.39 | |
| Matthew Custodio | Boston, MA | $50,000.00 | |
| Jiun-Ruey Hu | New Haven, CT | $37,975.23 | |
| Ana Becerra | Farmington, CT | $20,000.00 | |
| Yousif Alsaiegh | New York, NY | $15,426.52 | |
| Kavin Joseph Pushparaj | La Jolla, CA | $15,372.86 | |
| Laura Bradel | Elmira, NY | $12,710.52 | |
| Filippo Filicori | New York, NY | $12,129.40 | |
| Natasha Topoluk | Milwaukee, WI | $10,140.53 | |
| Charlie Lin | Los Angeles, CA | $10,041.53 |
Prescribed Accolade Sr?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.